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Intercurrent clinical events are predictive of plasma C-reactive sistance [1, 2], dialysis related amyloidosis [3], malnutri-
protein levels in hemodialysis patients. tion [4], and both cardiovascular [5, 6] and overall mortal-
Background. In chronic hemodialysis (HD) patients, the re- ity (abstract; Bergstro¨m J, J Am Soc Nephrol 54:573,petitive induction of the acute phase response (APR) may
1995) [7]. According to recent literature, an increasedinduce a chronic micro-inflammatory state, leading to various
APR has been associated with both the type of dialyzerlong-term complications.
Methods. The present prospective study was designed to [8, 9] and the presence of contaminated dialysate [10, 11].
assess the alterations in the APR in 74 patients who were ran- As for the latter, apparently contradictory viewpoints
domized to HD with a high-flux polysulfone (PS; F 60S), a
have been described. On the one hand, dialyzers withsuper-flux PS (F 500S), or a super-flux cellulosic tri-acetate
high permeability characteristics have been associated(CTA and CTA with filtered dialysate, CTAf) dialyzer. Blood
samples collected at the start of the study and after twelve with an increased risk of back-transport, defined as the
weeks were analyzed for interleukin-6 (IL-6) and C-reactive transfer of bacterially derived substances from the dialy-
protein (CRP). In addition to the microbiological quality of sate to the blood compartment, leading to the inductionthe dialysate, the appearance of a “clinical event” was assessed.
of pro-inflammatory cytokines [12, 13]. On the otherResults. At baseline, mean IL-6 levels were within the refer-
hand, however, in the case of high flux polysulfone (PS)ence range whereas mean CRP levels were slightly elevated.
Mean values did not change after 12 weeks of HD with either and polyamide membranes, it has been demonstrated
modality. After subdividing the patients in quartiles with in- that back-transport is largely prevented by the formation
creasing change in plasma CRP, 23.0% of the patients showed a of a protein layer at the blood side and/or its ability tochange of more than 8.0 mg/L. In a multiple regression analysis,
adsorb bacterially derived products onto the hydropho-CRP levels appeared to be independent of the degree of dialy-
sate contamination, the material and the flux characteristics of bic domains within the membrane. As (modified) high-
the devices. In fact, the variable “clinical events” was the only flux cellulosic dialyzers consist entirely of hydrophilic
significant predictor of the plasma CRP levels (P  0.001). domains that lack the capacity to adsorb these substances
Conclusions. Based on these results, both PS and CTA su-
[14], concern has been raised that patients who areper-flux dialyzers appear safe for clinical use. Whether changes
treated with these devices are at a high risk of exposurein CRP values, which are associated with intercurrent clinical
events, influence the long-term prognosis of chronic HD pa- to bacterial contaminants in the dialysate [15–17].
tients remains to be established. Recently, devices with superior permeability charac-
teristics for potentially harmful middle and large molecu-
lar weight substances, such as leptin [18, 19], 2-micro-
In chronic hemodialysis (HD) patients, the repetitive globulin [20], uremic toxins involved in the extra-renal
induction of the acute phase response (APR) may induce homocysteine metabolism [21], and advanced glycation
a chronic micro-inflammatory state, leading to a variety end products (AGEs) (abstract; Van Tellingen A, J Am
of long-term complications, including erythropoietin re- Soc Nephrol 10: 308A, 1999), were introduced at our
center [21]. In a previous study of these super-flux dialyz-
ers that compared low to moderately contaminated dialy-Key words: super-flux dialyzers, interleukin-6, C-reactive protein, dial-
ysate contamination, back-transport, polysulfone, cellulosic tri-acetate. sate with ultra-pure dialysate, endotoxin (ETX) concen-
trations in the plasma, as measured by the limulusReceived for publication August 28, 2001
amebocyte lysate (LAL) assay, were consistently belowand in revised form February 7, 2002
Accepted for publication March 8, 2002 the values in the dialysate [22]. Moreover, during HD
with CTA dialyzers these values even decreased, sug- 2002 by the International Society of Nephrology
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Table 1. Membrane characteristicsgesting that back-transport of LAL-positive material did
not occur. However, apart from LAL-positive material, F 60S F 500S CTA
other cytokine-inducing substances (CIS), such as exo- Inner lumen lm 200 155 200
Wall thickness lm 40 35 15toxins and outer membrane proteins (peptidoglycans,
UF coefficient mL/mm Hg/h 40 300 (H2O) 29muramyl-peptides) [14], may cross the membrane of the
Surface area m2 1.3 1.2 1.5
dialyzer and elicit an APR in HD patients. Therefore, Clearance mL/min
2-microglobulin (MW 11.8 kD) 38 65–80 no datathe present study was designed to detect changes in the
Sieving coefficientAPR, as measured by plasma interleukin-6 (IL-6) and
2-microglobulin 0.65 0.9 0.8C-reactive protein (CRP), in chronic HD patients who
Abbreviations are: F 60S, high-flux polysulfone; F 500S, super-flux polysulfone;were randomized either to HD with highly permeable CTA, super-flux cellulosic tri-acetate; UF, ultrafiltration; MW, molecular weight.
super-flux dialyzers (PS, CTA and CTA with an ETX
filter, CTAf) or to HD with a standard high-flux dialyzer
(PS). As not only alterations in the treatment modality,
sult in a better convective clearance of middle and highbut also intercurrent clinical events might have a marked
molecular weight substances, as measured by 2-micro-influence on changes in plasma CRP levels, the medical
globulin (Vienken J, personal communication). Filteredconditions of the patients were recorded both at the time
dialysate was obtained by the interposition of a PS filterof inclusion and regularly during the follow-up period.
(SPS 600; Fresenius) [23]. According to the individual
needs of the patients, blood flow and UF rates were kept
METHODS constant between 200 and 250 mL/min and 300 and 1000
Study design mL/h, respectively. Isolated UF was not performed. Bi-
carbonate powder (BiBag; Fresenius) was used for theSeventy-four patients, (median age 70 years, range
preparation of the dialysate. Dialysate flow was 500 mL/26 to 87), undergoing HD for at least six months (me-
min. Anticoagulation was achieved by dalteparin withdian 37, range 8 to 301) with a high-flux PS dialyzer
an initial dose of 2500 to 6000 IU, followed by an extra(F60S), which is the “gold standard” in our center, partic-
dose of 500 to 1000 IU during the dialysis treatment ifipated in the study after giving written informed consent.
necessary. Individual conditions (blood flow, UF, daltep-Exclusion criteria at the entry of the study were use of
arin dose) were kept stable throughout the study period.a percutaneous HD catheter, co-morbidity (malignancy,
auto-immune disease and/or acute infections), and/or
Clinical eventsmedication (NSAIDs, prednisone) that might interfere
Clinical conditions that might interfere with the APR,with the immune system.
including infections, surgical interventions, and inflam-All patients were randomized to HD with either a
matory or injurious conditions that may elicit tissue dam-high-flux PS (F 60S), a super-flux PS (F 500S), a super-
age, were assessed prospectively during the follow-up offlux CTA (Tricea 150G), or a super-flux CTA dialyzer
the study. In addition, each hospitalization was recorded.with filtered dialysate (Tricea 150Gf) for 12 consecutive
weeks. Blood samples were collected both at the start
Analytical methodsof the study and after twelve weeks. Blood samples were
Microbiological evaluation of the dialysate. Dialysatedrawn from the afferent line before dialysis (t0) and ana-
samples were drawn in sterile tubes. Total plate countslyzed for IL-6 and CRP. Dialysate samples were taken
were performed on Reasoners 2A-agar (Difco Labora-at t180 from the outlet port of the dialysis machine and
tories, Detroit, MI, USA) after 24 hours of incubationwere cultured for bacterial growth and analyzed for
at 37C and 7 days at 21C. Isolation of pathogens wereLAL-reactivity.
performed on McConkey-agar (Becton-Dickinson, Hei-
Dialysis procedure and materials delberg, Germany) after 48 hours of incubation at 37C.
Identification of micro-organisms was achieved usingThe dialysis sessions lasted three to five hours, de-
Analytical Profile Index identification (Analytical Profilepending on the individual prescription of the patient.
Index system S.A., Montalieu Verceu, France).Only first-use dialyzers were used. Characteristics of the
Endotoxin assay. Dialysate samples for ETX determi-three dialyzers used in this study (PS F 60S and F 500S
nations were collected in pyrogen-free and sterile FAL-from Fresenius, Bad Homburg, Germany; CTA Tricea
CON 2063 polypropylene tubes (Becton Dickinson).150G; Baxter, Osaka, Japan) are depicted in Table 1.
Samples were stored at20C until determination. ETX-As for the super-flux dialyzers, these devices have been
activity in dialysate was quantified by a kinetic chromo-designed to maximize convective transport by increasing
genic method based on the LAL-assay (BioWhittaker,the pressure drop along the fibers of the membrane.
Walkersville, MD, USA). Standard series of purifiedFurthermore, the pore size and/or the distribution of the
pores influence the permeability. These characteristics re- Escherichia coli 055:B5 lipopolysaccharide (LPS) were
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Table 3. Medical conditions at the time of CRP measurementsTable 2. Patient characteristics
during the follow-up of the study
F 60S F 500S CTA CTAf Total
Clinical events N
Patients N 19 19 19 17 74
Age years 6515 6711 6614 6815 6613 Infections 9
Shunt complications 5Gender female/male 9/10 6/13 9/10 10/7 34/40
Time on HD months 7678 5051 5868 5644 6062 Diabetic/vascular ulcer 3
Heart failure 1Type of vascular access
fistula/graft 8/11 4/15 3/16 8/9 23/51 Total hip replacement 1
Subdural haematoma 1Data are mean  SD.
made in the range 0.005 to 50.0 EU/mL. Inhibition and tients had arteriovenous fistulas for vascular access,
interference testing was performed on each sample by whereas twenty patients had artificial subcutaneous grafts.
an ETX spike. To overcome inhibition/enhancement, all
Clinical eventsdialysate samples were diluted 10 times. All determina-
tions were performed in duplicate and recoveries of The patients were free of acute events at the start of
spikes between 50 and 150% were accepted. Limit of the study, whereas the clinical events occurred during the
determination was 0.05 EU/mL. observation time. A summary of the patients with medi-
Interleukin 6. IL-6 was determined in K3-EDTA plasma cal conditions are depicted in Table 3. Infections were
by a sandwich-type immunoassay, according to the man- generally mild and included influenza in seven patients
ufacturer’s procedures (Central Laboratory, Nether- and cystitis in two patients. Shunt complications con-
lands Red Cross Blood Transfusion Service, Amsterdam, sisted of one contusion, one hematoma and an infection
The Netherlands) [24]. After centrifugation (10 min, of the shunt in three patients, and repair of the arteriove-
1500  g), the plasma samples were stored immediately nous fistula in two patients. Other medical conditions
at 70C until required for testing. The lower limit of included: diabetic or vascular ulcer in three patients, and
detection for IL-6 was 0.3 pg/mL. IL-6 reference value congestive heart failure, a total hip replacement and a
of healthy individuals was below 10 pg/mL. subdural hematoma in one patient. Of these patients,
C-reactive protein. Serum CRP concentrations were de- seven (35.0%) were hospitalized at the time of the blood
termined by nephelometry (BN II; Dade Behring B.V., sample measurements. Marked differences in the num-
Leusden, The Netherlands). The lower limit of detection ber of clinical events were not observed between the
of CRP was 2 mg/L. CRP reference values for healthy
four study groups.
individuals were below 5 mg/L.
Microbiological quality of the dialysateStatistical analysis
For the bacterial counts, gram-positive organisms wereData are expressed as mean ( SD). Analysis was
cultured in 8 of 74 cases, whereas 7 out of 8 also showedperformed with the Statistical Package for Social Sci-
gram-negative organisms. When comparing filtered withences/PC software system using paired and unpaired
non-filtered dialysate, a significant difference was ob-t tests to study the differences between groups. Categori-
served [filtered dialysate 0 (0–3) CFU/mL; non-filteredcal variables were compared using the 2-test. Correla-
dialysate 26 (0–310) CFU/mL, P 0.001]. Pseudomonastion coefficients were calculated with the Pearson method.
species were not isolated.Multiple linear regression, stepwise method (entry at 5%
As for ETX concentrations, marked differences wereand removal at 10%), was used to evaluate the influence
not found between filtered and non-filtered dialysateof the independent predictors on the change of CRP
(filtered dialysate 0.051  0.005 EU/mL, non-filteredlevels after 12 weeks of HD. After subdividing the pa-
dialysate 0.051  0.005 EU/mL; P 	 NS; Table 4).tients into four groups with increasing change of CRP
levels, a logistic regression analysis was applied to each
Interleukin-6quartile separately. Differences were considered statisti-
At baseline, mean values were within the referencecally significant at P  0.05.
range. IL-6 levels remained stable after 12 weeks of HD
with all four modalities (F 60S week 1, 2.3  1.2 pg/mL
RESULTS and week 12, 2.6  1.5 pg/mL, P 	 NS; F 500S week 1,
Patient characteristics 2.9  2.0 pg/mL and week 12, 3.3  3.3 pg/mL, P 	 NS;
CTA week 1, 1.9  0.9 pg/mL and week 12, 2.0  1.0There were no significant differences in age, gender,
pg/mL, P 	 NS; CTAf week 1 4.2  3.8 pg/mL andtime on HD, or vascular access type (fistula or graft) be-
tween the four patient groups (Table 2). Fifty-four pa- week 12, 2.7  2.1 pg/mL, P 	 NS; Fig. 1).
van Tellingen et al: Acute phase response in HD 635
Table 4. Dialysate cultures and endotoxin concentrations
Non-filtered dialysate Filtered dialysate
Characteristic (N 	 55) (N 	 19)
Dialysate culture CFU/mLa 26 (0–310)b 0 (0–3)b,c
Gram stain number
Positive 1 0
Negative 43 1
Positive and negative 7 0
None 4 18
Endotoxin EU/mLd 0.051 (0.05–0.086) 0.051 (0.05–0.071)e
a Colony-forming unit
b Median (range)
c P  0.001, filtered versus non-filtered dialysate
d Endotoxin unit per milliliter
e P 	 0.47, filtered versus non-filtered dialysate
C-reactive protein
Baseline CRP levels were slightly elevated when com-
pared to the reference value for healthy individuals. Sig-
nificant differences were not observed between the four
modalities at the start of the study (F 60S, 6.9 5.6 mg/L;
F 500S, 6.7  6.8 mg/L; Tricea 150G, 6.7  5.9 mg/L;
Tricea 150Gf, 16.7 20.2 mg/L; P	NS). Marked fluctu-
ations were not observed after 12 weeks of HD (Fig. 1).
After subdividing the patients into four groups (quartiles)
with increasing change in CRP after 12 weeks of HD,
29.7% of the patients showed no change, 20.3% showed
a change between 0.1 and 3.0 mg/L, 25.7% showed a change
between 3.1 and 8.0 mg/L, and 23.0% showed a change
of more than 8.0 mg/L (Fig. 2).
Fig. 1. Plasma interleukin-6 (IL-6; A) and C-reactive protein (CRP; B)
levels at the start of the study and after 12 weeks of HD with fourRelationship between markers of dialysate quality dialyzer modalities. Significant changes in mean values were not ob-
(bacterial counts and ETX), type of dialyzer, type served, nor were there marked differences between the four dialyzer
modalities. Symbols are: () F 60; ( ) F 500S; ( ) CTA; ( ) CTAf.of vascular access, clinical events, IL-6 and CRP levels
By univariate regression analysis, significant correla-
tions were not found between the bacteriological quality
of the dialysate and CRP levels. A strong positive corre-
lation was found between IL-6 and CRP levels (r	 0.85,
P  0.001; Fig. 3). Moreover, a significant correlation
was observed between the appearance of a “clinical
event” and CRP levels (r 	 0.44, P  0.001). Interest-
ingly, the parameter “clinical events” showed an even
stronger correlation with the change of CRP levels in
the highest quartile (that is, CRP change 
8.0 mg/L).
Using a stepwise multiple linear regression model with
the change of CRP levels after 12 weeks of HD as the
dependent variable and the already mentioned parame-
ters as independent factors, the appearance of a “clinical
event” during the follow-up was the only significant pre- Fig. 2. Subdivision of the patients into four groups with increasing
change of CRP levels during the follow-up of the study.dictor of the CRP changes, accounting for 22.1% of its
variance (P  0.001; Table 5). Moreover, using subse-
quently the highest quartile (that is, CRP change 
8.0
DISCUSSIONmg/L) as the dependent variable in this model, the ap-
The present study was designed to assess potentialpearance of a clinical event again remained the only
changes in the APR over a period of twelve weeks insignificant predictor of CRP, accounting for 36.2% of its
variance (P  0.001). chronic HD patients who were randomized to two types
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Table 5. Multiple linear regression, stepwise method,
with the change of CRP levels after 12 weeks of HD
as the dependent variable
R2 beta P value
(Constant) 4.6 0.16
Clinical event 0.221 27.4 0.001
Bacterial counts in dialysate culture
(CFU/mL)a 0.59
Endotoxins (dialysate) (EU/mL)b 0.67
Membrane material 0.77
Type of vascular access dialyzer 0.44
F 60S 0.18
F 500S 0.30
CTA 0.54
CTAf 0.77
The appearance of a clinical event during the follow-up remained the only
significant predictor of CRP accounting for 22.1% of its variance.
a Colony-forming unit per milliliter
b Endotoxin unit per milliliterFig. 3. Correlation between IL-6 and CRP levels. A strong correlation
was noted (r 	 0.85, P  0.001).
correlated with either the type of dialyzer or the bacterial
quality of the dialysate.
of super-flux dialyzers, the F 500S consisting of synthetic Recently, patient-related factors, such as chronic bac-
material (PS) and the CTA consisting of modified cellu- terial infections (Helicobacter Pylori, Chlamydia Pneu-
lose. In the case of CTA, both a modality with standard moniae), smoking habit and the presence of cardiovascu-
dialysate (26 CFU/mL, range 0 to 310) and ultra-pure lar disease have been recognized as important contributors
to plasma CRP levels in individuals with and withoutdialysate was used (0 CFU/mL, range 0 to 3). Patients
renal diseases [26, 27]. However, as the change in CRPrandomized to a high-flux PS device (F 60S) served as
levels over a period of 12 weeks was the principal objec-controls, as this type of dialyzer is the “gold standard”
tive of this study, these relatively stable patient-depen-in our center.
dent determinants of plasma CRP were not consideredAt baseline, mean IL-6 levels were within the refer-
in the present analysis.ence range in all groups, whereas plasma CRP levels
Only a limited number of investigations have ad-were slightly elevated. After 12 weeks of HD, mean
dressed the influence of HD-related factors on the APRvalues of these measurements did not change, in either
in clinical bicarbonate HD. Recently, we published anmodality. In line with previous studies on IL-6 and CRP
intra-dialytic study comparing both cuprammonia (CU),in chronic HD patients [8, 25], a strong correlation was
CU with a bacterial filter (CUf) and PS dialyzers [8].found between these two markers of inflammation. In a
Plasma IL-6 and CRP were assessed both before, at themultiple linear regression analysis, CRP levels appeared
end, and 24 hours after HD. From this study it appearedindependent of the degree of dialysate contamination,
that, whereas PS induced no changes at all, both CUdespite significant differences in the number of CFU/mL
and Cuf induced a marked rise in IL-6 at t180, whichbetween filtered and non-filtered dialysate. In addition,
correlated with an increase in plasma CRP after 24 hours.
neither the material (CTA and PS), nor the flux charac-
Comparable data were recently published in a crossover
teristics of the devices (high-flux and super-flux) influ- analysis of stable HD patients [9]. According to this
enced CRP levels. In fact, the appearance of a “clinical report the HD-induced inflammatory reaction was mark-
event” was the only significant predictor of CRP, ac- edly affected by the type of material, CU eliciting higher
counting for 22.1% of its variance. After subdividing the CRP levels than dialyzers with the synthetic membranes
patients into quartiles with increasing change in CRP polyamide and polycarbonate. Of note, the degree of
levels, 23.0% showed a change of more than 8.0 mg/L. bacterial contamination of the dialysate in the latter
Moreover, after the application of a logistic regression study was comparable with the standard dialysate in the
analysis to each quartile separately, the appearance of a present analysis: 20.5  5.8 and 26 (range 0 to 310)
“clinical event” during follow-up was the only significant CFU/mL, respectively. Likewise, in a study of chronic
predictor of CRP changes in the highest quartile (that HD patients who were treated with PS membranes only,
is, CRP change 
8.0 mg/L), accounting for 36.2% of its plasma CRP levels were independent to the presence of
variance. In a separate analysis restricted to the patients a bacterial filter, whereas there was a large difference in
showing no acute events during the study, marked the degree of contamination between ultra-pure and
changes in CRP levels did not occur (data not shown). non-filtered dialysate (0 and 95 CFU/mL, respectively;
range 14 to 1000 CFU/mL) [14]. Our findings are in lineIn addition, in this patient group CRP levels were not
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with the latter two clinical investigations, suggesting that tercurrent clinical events, influence the long-term prog-
nosis of chronic HD patients remains to be established.low to moderate dialysate contamination has no marked
influence on CRP levels in chronic HD patients.
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